Synthesis, characterization and antitumor activity of platinum(II) complexes with diethyl and monoethyl 2-quinolylmethylphosphonates

Journal of Inorganic Biochemistry

Volumn 95, Issue 4, 2003, Pages 259-269

  Tušek Božić, Ljerka ^a   Frausin, Fabiana ^b   Scarcia, Vito ^b   Furlani, Ariella ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

1H NMR; Antitumor activity; Infrared; Platinum(II) complex; Quinolylmethylphosphonate complex

Indexed keywords

ANION; CATION; CHELATE; DIETHYL 2 QUINOLYLMETHYLPHOSPHONATE; HALIDE; MONOETHYL 2 QUINOLYLMETHYLPHOSPHONATE; PHOSPHONIC ACID DERIVATIVE; PLATINUM COMPLEX; QUINOLINE DERIVATIVE; QUINOLINE NITROGEN; QUINOLINIUM HEXAHALODIPLATINUM DERIVATIVE; TETRAHALOPLATINATE; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL BOND; CHEMICAL REACTION; CONDUCTOMETRY; CONTROLLED STUDY; CYTOSTASIS; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED RADIATION; MOUSE; NONHUMAN; PH; PROTON NUCLEAR MAGNETIC RESONANCE; PROTON TRANSPORT; STRUCTURE ACTIVITY RELATION; THERMOGRAVIMETRY;

MURINAE;

EID: 17344379605     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(03)00124-7     Document Type: Article

References (49)

1. Weiss R.B., Cristian M.C. Drugs. 46:1993;360-377.
2. O'Dwyer P.J., Stevenson J.P., Johnson S.W. Clinical status of cisplatin, carboplatin, and other platinum-based antitumor drugs. Lippert B. Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. 1999;31-72 VHCA and Wiley-VCH, Zürich and Weinheim.
3. Bierbach U., Qu Y., Hambley T.W., Proutka J., Nguyen H.L., Doedee M., Farrell N. Inorg. Chem. 38:1999;3535-3542.
4. Natile G., Coluccia M. Coord. Chem. Rev. 216-217:2001;383-410.
5. Perez J.M., Fuertes M.A., Alonso C., Navarro-Ranninger C. Crit. Rev. Oncol. Hematol. 35:2000;109-120.
6. Abrams M.J., Picker D.H., Fackler P.H., Lock C.J.L., Howard-Lock H.E., Faggiani R., Teicher B.A., Richmond R.C. Inorg. Chem. 25:1986;3980-3983.
7. Lopez-Solera I., Perez J.M., Monge M.A., Alvarez-Valdes A., Masaguer J.R., Alonso C., Navarro-Ranninger C. J. Inorg. Biochem. 56:1994;233-242.
8. Farrell N., Qu Y., Bierbach U., Valsecchi M., Menta E. Structure-activity relationships within di- and trinuclear platinum phase I clinical anticancer agents. Lippert B. Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. 1999;479-496 VHCA and Wiley-VCH, Weinheim and Zürich.
9. Goddard P.M., Orr R.M., Valenti M.R., Barnard C.F., Murrer B.A., Kelland L.R., Harrap K.R. Anticancer Res. 16:1996;33-38.
10. Lebwohl D., Canneta R. Eur. J. Cancer. 34:1998;1522-1534.
11. Lee H.H., Palmer B.D., Baguley B.C., Chin M., McFayden W.D., Wickham G., Thorsbournepalmer D., Wakelin L.P.G., Denny W.A. J. Med. Chem. 35:1992;2983-2987.
12. Gibson D., Mansur N., Gean K.F. J. Inorg. Biochem. 58:1995;79-88.
13. Sachinvala N.D., Chen H., Niemczura W.P., Furusawa E., Cramer R.E., Rupp J.J., Ganjian I. J. Med. Chem. 36:1993;1791-1795.
14. Kopfmaier P. Eur. J. Clin. Pharmacol. 47:1994;1-16.
15. Clarke M.J., Zhu F., Frasca D.R. Chem. Rev. 99:1999;2511-2534.
16. Perrin L.C., Prenzler P.D., Cullinane C., Phillips D.R., Denny W.A., McFadyen W.D. J. Inorg. Biochem. 81:2000;111-117.
17. Lj. Tušek-Božić, I. Matijašić, G. Bocelli, G. Calestani, A. Furlani, V. Scarcia, A. Papaioannou, J. Chem. Soc. Dalton. Trans. (1991) 195-201.
18. Tušek-Božić Lj., Matijašić I., Bocelli G., Sgarabotto G., Furlani A., Scarcia V., Papaioannou A. Inorg. Chim. Acta. 185:1991;229-237.
19. Klenner T., Valenzuela-Paz P., Amelung F., Münch H., Zahn H., Keppler B.K., Blum H. Platinum phosphonato complexes with particular activity against bone malignancies. An evaluation of an experimental model highly predictive for the clinical situation. Keppler B.K. Metal Complexes in Cancer Chemotherapy. 1993;85-127 VCH, Weinheim.
20. Bloemink M.J., Dorenbos J.P., Heeterbij R.J., Keppler B.K., Reedijk J., Zahn H. Inorg. Chem. 33:1994;1127-1132.
21. Ćurić M., Tušek-Božić Lj., Vikić-Topić D., Scarcia V., Furlani A., Balzarini J., De Clercq E. J. Inorg. Biochem. 63:1996;125-142.
22. Brzezinska-Blaszczyk E., Mincikiewicz M., Ochocki J. Eur. J. Pharmacol. 298:1996;155-158.
23. Tušek-Božić Lj., Furlani A., Scarcia V., De Clercq E., Balzarini J. J. Inorg. Biochem. 72:1998;201-210.
24. Bloemink M.J., Diederen J.H., Dorenbos J.P., Heeterbij R.J., Keppler B.K., Reedijk J. Eur. J. Inorg. Chem. 10:1999;1655-1657.
25. Tušek-Božić Lj., D'Alpaos. Polyhedron. 17:1998;1481-1493.
26. Tušek-Božić Lj., Komac M., Ćurić M., Lyčka A., D'Alpaos M., Scarcia V., Furlani A. Polyhedron. 19:2000;937-948.
27. Tušek-Božić Lj., D'Alpaos M., Ćurić M., Lyčka A. Croat. Chem. Acta. 74:2001;825-836.
28. Jagodić V., Božić B., Tušek-Božić Lj., Herak M.J. J. Heterocycl. Chem. 17:1980;685-688.
29. Craciunescu D.G., Scarcia V., Furlani A., Doadrio A., Ghirvu C., Ravalico L. In Vivo. 1:1987;229-234.
30. Marcheselli L., Preti C., Tagliazucchi M., Cerchi V., Sindellari L., Furlani A., Papaioannou A., Scarcia V. Eur. J. Med. Chem. 28:1993;347-352.
31. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1107-1112.
32. Tallarida R.J., Murray R.B. Manual of Pharmacological Calculations with Computer Programs. 1987;Springer, New York.
33. Tušek-Božić Lj., Trojko R. Thermochim. Acta. 339:1999;41-45.
34. Guo Z., Faraglia G., Sitran S. Polyhedron. 13:1994;659-665.
35. Thomas L.C. Interpretation of Infrared Spectra of Organophosphorus Compounds. 1974;39-45 Plenum, New York.
36. Tušek-Božić Lj. Vib. Spectrosc. 28:2002;235-241.
37. Nakamoto K. Infared and Raman Spectra of Inorganic and Coordination Compounds, Part B: Applications in Coordination Organometallic and Bioinorganic Chemistry. 5th Edition:1997;24 and 59 Wiley-Interscience, New York.
38. Tušek-Božić Lj., Matijašić I., Ćurić M. J. Mol. Struct. 267:1992;87-91.
39. Tušek-Božić Lj., Trojko R. Thermochim. Acta. 189:1991;175-183.
40. Herlinger A.W., Ferraro J.R., Chiarizia R., Horwitz E.P. Polyhedron. 11:1997;1843-1854.
41. Anklin C.G., Pregosin P.S. Mag. Reson. Chem. 23:1985;671-675.
42. Albinati A., Pregosin P.S., Wombacher F. Inorg. Chem. 29:1990;1812-1817.
43. Stang P.J., Olenyuk B., Arig A.M. Organometallics. 14:1995;5281-5289.
44. Bierbach U., Farell N. Inorg. Chem. 36:1997;3657-3665.
45. Scolaro R.M., Mazzaglia A., Romeo A., Plutino M.R., Castriciano M., Romeo R. Inorg. Chim. Acta. 330:2002;189-196.
46. Tušek-Božić Lj., Ćurić M., Vikić-Topić D., Lyčka A. Collect. Czech. Chem. Commun. 62:1997;1888-1904.
47. Tušek-Božić Lj., Lyčka A. Magn. Reson. Chem. 40:2002;175-181.
48. Van Beusichem M., Farell N. Inorg. Chem. 31:1992;634-639.
49. J. Reedijk, Chem. Commun. (1996) 801-806.